Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract

核糖核酸酶 7:人类肾脏和尿路的抗菌活性

基本信息

项目摘要

DESCRIPTION (provided by applicant): The candidate's long-term goal is to become an accomplished independent physician-scientist in academic pediatric nephrology with clinical and research expertise in the diagnosis, treatment, and prevention of urinary tract infections (UTI). This mentored K08 Career Development Award proposal outlines a plan where the candidate will train under the guidance of a team of mentors and collaborators that have a successful track record of working together. This Research Advisory Team has extensive experience and success in guiding trainees and junior faculty to successful careers as independent physician-scientists. The candidate will benefit from state-of-the-art facilities and extensive support from clinical, basic, and general core services. He will acquire new research and analytical skills from hands-on directed laboratory mentorship and a classroom- based education at The Ohio State University. He will build a repertoire of competencies in oral and written scientific communication; academic team leadership and collaboration; and grantsmanship. The long-term objectives of the proposed research project are to improve the care of pediatric patients with UTIs by identifying effective early biomarkers and novel treatment options for the diagnosis and treatment of UTIs. The proposed research project will test the hypothesis that antimicrobial peptides (AMP), a ubiquitous component of the innate immune system, are important in the regulation and prevention of UTIs. The proposed research will define the function of a novel AMP, ribonuclease 7 (RNase 7), which has recently been shown to have potent antimicrobial properties and play an important role in maintaining urinary tract sterility. The anticipated outcome of this work is advancement of our understanding of the role of RNase 7 in the prevention and treatment of UTIs and to identify the potential use of this protein in UTI diagnostics and therapeutics. Specific Aim 1 is designed to characterize the antimicrobial properties of RNase 7 in states of health and infection. Specific Aim 2 is designed to characterize RNase 7 at the structural and functional level by identifying critical amino acid residues that are responsible for its antimicrobial function. Specific Aim 3 is designed to evaluate the frequency and biological relevance of single nucleotide polymorphisms in RNASE7. Successful completion of these proposed aims and educational plan will help develop the needed expertise to systematically evaluate AMPs, like RNase 7, in the human urinary tract.
描述(由申请人提供):候选人的长期目标是成为学术儿科肾脏学领域的独立医师科学家,并具有诊断,治疗和预防尿路感染(UTI)方面的临床和研究专业知识。这项指导的K08职业发展奖提案概述了一项计划,其中候选人将在一群导师和合作者的指导下进行培训,这些团队与合作成功的记录有了成功的记录。该研究咨询团队在指导学员和初级教师的职业生涯中具有丰富的经验和成功,成为独立的医师科学家。候选人将从最先进的设施中受益,并从临床,基本和一般核心服务中获得广泛的支持。他将从 俄亥俄州立大学的实践实验室指导和基于教室的教育。他将建立口头和书面科学交流能力的曲目;学术团队的领导与协作;和授予技巧。拟议的研究项目的长期目标是通过识别有效的早期生物标志物和新型治疗选择来改善尿路运动的儿科患者的护理,以诊断和治疗UTI。拟议的研究项目将检验以下假设:抗菌肽(AMP)是先天免疫系统的无处不在组成部分,对UTI的调节和预防至关重要。拟议的研究将定义一种新型放大器核糖核酸酶7(RNase 7)的功能,该功能最近已被证明具有有效的抗菌特性,并在维持尿路不育方面起着重要作用。这项工作的预期结果是我们对RNase 7在预防和治疗UTI的作用的理解的发展,并确定该蛋白在UTI诊断和治疗剂中的潜在使用。特定目标1旨在表征卫生和感染状态中RNase 7的抗菌特性。特定的目标2旨在通过识别负责其抗菌功能的关键氨基酸残基来表征在结构和功能水平上的RNase 7。特定目标3旨在评估RNase7中单核苷酸多态性的频率和生物学相关性。这些拟议的目标和教育计划的成功完成将有助于发展人类尿路中系统评估RNase 7之类的AMP所需的专业知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John David Spencer其他文献

Urinary Tract Infections in Children
儿童尿路感染
  • DOI:
    10.1007/978-3-642-27843-3_49-2
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Giovanni Montini;John David Spencer;I. Hewitt
  • 通讯作者:
    I. Hewitt

John David Spencer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John David Spencer', 18)}}的其他基金

Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility
胰岛素信号激活尿路上皮防御,降低尿路感染易感性
  • 批准号:
    10364241
  • 财政年份:
    2021
  • 资助金额:
    $ 12.91万
  • 项目类别:
Insulin Signaling Activates Urothelial Defenses to Reduce Urinary Tract Infection Susceptibility
胰岛素信号激活尿路上皮防御,降低尿路感染易感性
  • 批准号:
    10673963
  • 财政年份:
    2021
  • 资助金额:
    $ 12.91万
  • 项目类别:
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses
将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来
  • 批准号:
    9883788
  • 财政年份:
    2018
  • 资助金额:
    $ 12.91万
  • 项目类别:
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses
将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来
  • 批准号:
    10113589
  • 财政年份:
    2018
  • 资助金额:
    $ 12.91万
  • 项目类别:
The Contribution of Ribonuclease 7 to Urinary Tract Anitbacterial Defense
核糖核酸酶 7 对尿路抗菌防御的贡献
  • 批准号:
    9897601
  • 财政年份:
    2018
  • 资助金额:
    $ 12.91万
  • 项目类别:
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial Defenses
将胰岛素信号转导与抗菌肽的产生和肾脏的抗菌防御联系起来
  • 批准号:
    9523793
  • 财政年份:
    2018
  • 资助金额:
    $ 12.91万
  • 项目类别:
The Contribution of Ribonuclease 7 to Urinary Tract Anitbacterial Defense
核糖核酸酶 7 对尿路抗菌防御的贡献
  • 批准号:
    10348147
  • 财政年份:
    2018
  • 资助金额:
    $ 12.91万
  • 项目类别:
Novel Mouse Models to Assess the in vivo Significance of Ribonuclease 7 in Urinary Tract Defense
评估核糖核酸酶 7 在尿路防御中体内意义的新型小鼠模型
  • 批准号:
    9091881
  • 财政年份:
    2016
  • 资助金额:
    $ 12.91万
  • 项目类别:
Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract
核糖核酸酶 7:人类肾脏和尿路的抗菌活性
  • 批准号:
    8461667
  • 财政年份:
    2012
  • 资助金额:
    $ 12.91万
  • 项目类别:
Ribonuclease 7: Antimicrobial Activity in the Human Kidney and Urinary Tract
核糖核酸酶 7:人类肾脏和尿路的抗菌活性
  • 批准号:
    8917937
  • 财政年份:
    2012
  • 资助金额:
    $ 12.91万
  • 项目类别:

相似国自然基金

基于祖先序列重构的D-氨基酸解氨酶的新酶设计及分子进化
  • 批准号:
    32271536
  • 批准年份:
    2022
  • 资助金额:
    54.00 万元
  • 项目类别:
    面上项目
模板化共晶聚合合成高分子量序列聚氨基酸
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
模板化共晶聚合合成高分子量序列聚氨基酸
  • 批准号:
    22201105
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于祖先序列重构的D-氨基酸解氨酶的新酶设计及分子进化
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
C-末端40个氨基酸插入序列促进细菌脂肪酸代谢调控因子FadR转录效率的机制研究
  • 批准号:
    82003257
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
  • 批准号:
    10678341
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
Variant Validation Core
变体验证核心
  • 批准号:
    10747721
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
Myocardial Physiology of Growth Differentiation Factor Signaling
生长分化因子信号传导的心肌生理学
  • 批准号:
    10711086
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
Investigating the Role of SLC45A4 in GABA Metabolism
研究 SLC45A4 在 GABA 代谢中的作用
  • 批准号:
    10635402
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了